Guidance for development of chemopreventive agents.
Kelloff
G J
GJ
Chemoprevention Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland 20892, USA.
Johnson
J R
JR
Crowell
J A
JA
Boone
C W
CW
DeGeorge
J J
JJ
Steele
V E
VE
Mehta
M U
MU
Temeck
J W
JW
Schmidt
W J
WJ
Burke
G
G
D000818:Animals; D016588:Anticarcinogenic Agents / Q000493:pharmacokinetics; D002986:Clinical Trials as Topic / Q000592:standards; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004341:Drug Evaluation / Q000331:legislation & jurisprudence / Q000592:standards; D004353:Drug Evaluation, Preclinical; D017408:Guidelines as Topic; D006801:Humans; D051379:Mice; D011817:Rabbits; D051381:Rats; D018675:Toxicity Tests / Q000592:standards
D016588:Anticarcinogenic Agents